Introduction
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, first developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is a synthetic analogue of Epithalamin, a natural polypeptide extract derived from the pineal gland, and has been studied extensively in the context of ageing biology, telomere dynamics, and neuroendocrine regulation.
All Epitalon products supplied by Alpha Peptides are intended strictly for in vitro and laboratory research use only and are not approved for human or veterinary administration.
Background & Origins
The research programme that produced Epitalon began in the Soviet Union in the 1970s as part of a broader investigation into peptide bioregulators — short peptides derived from tissue extracts that were proposed to regulate gene expression in a tissue-specific manner. Khavinson’s group identified the tetrapeptide Ala-Glu-Asp-Gly as the minimal active sequence from pineal gland extracts and synthesised it as Epitalon for research purposes.
Over the following decades, Khavinson’s institute published an extensive body of research on Epitalon across multiple biological systems, with particular focus on its effects on telomere length, telomerase activity, and longevity in animal models.
Proposed Mechanisms of Action
- Telomerase activation: The most widely cited mechanism of Epitalon is its proposed ability to activate telomerase, the enzyme responsible for maintaining telomere length. Telomeres — the protective caps at the ends of chromosomes — shorten with each cell division, and telomere attrition is considered one of the hallmarks of cellular ageing. Research from Khavinson’s group has reported that Epitalon increases telomerase activity in human somatic cells, potentially slowing telomere shortening.
- Antioxidant activity: Studies have reported that Epitalon reduces markers of oxidative stress, including lipid peroxidation products and reactive oxygen species, in aged animal models. Oxidative stress is a key driver of cellular damage and ageing.
- Melatonin regulation: As a pineal-derived peptide, Epitalon has been studied for its effects on melatonin synthesis. Research has reported that Epitalon stimulates melatonin production in the pineal gland, which may contribute to its observed effects on circadian rhythm regulation and antioxidant activity (melatonin is itself a potent antioxidant).
- Gene expression modulation: Consistent with the broader peptide bioregulator model, Epitalon has been proposed to interact with chromatin and modulate gene expression in a tissue-specific manner, potentially upregulating genes associated with cellular repair and stress resistance.
Key Research Findings
Telomere & Longevity Research
The most significant published findings on Epitalon relate to telomere biology and longevity. Studies in human cell cultures have reported that Epitalon treatment activates telomerase and extends the replicative lifespan of somatic cells beyond the normal Hayflick limit. Animal studies have reported increased maximum lifespan in Epitalon-treated rodents compared to controls, with effects attributed to reduced oxidative damage and improved neuroendocrine function.
Cancer Research
A substantial portion of the Epitalon literature focuses on oncology, with studies reporting reduced tumour incidence and delayed tumour development in carcinogen-exposed rodents treated with Epitalon. The proposed mechanisms include antioxidant activity, immune modulation, and normalisation of neuroendocrine function. These findings have generated interest in Epitalon as a research tool for studying the relationship between ageing, neuroendocrine function, and cancer biology.
Neuroendocrine Research
Research has investigated Epitalon’s effects on the hypothalamic-pituitary axis, reporting normalisation of age-related changes in hormone secretion patterns in aged animal models. These findings are consistent with the pineal gland origin of the peptide and its proposed role in neuroendocrine regulation.
Retinal Research
Studies have investigated Epitalon in models of retinal degeneration, reporting protective effects on photoreceptor cells in aged rats with hereditary retinal dystrophy. This has generated interest in Epitalon as a research tool for studying age-related retinal pathology.
Research Considerations
- The majority of Epitalon research originates from a single research group (Khavinson et al.). Independent replication by other institutions is limited, and the field would benefit from larger, pre-registered studies using modern methodological standards.
- The proposed telomerase activation mechanism, while scientifically plausible, has not been fully characterised at the molecular level and the precise receptor or binding target of Epitalon remains unclear.
- Epitalon is a tetrapeptide and is generally considered stable, but standard peptide storage and handling protocols should still be followed.
- Refer to the Certificate of Analysis (COA) supplied with each batch for purity and sequence confirmation data.
Reconstitution & Storage
Epitalon should be reconstituted with bacteriostatic water to the required concentration. Store the reconstituted solution at 2–8°C and use within 28–30 days. For full guidance, refer to our Peptide Reconstitution Guide and Storage & Handling Guide.
Research Resources
Researchers can source Epitalon 10mg from Alpha Peptides, supplied with a full COA. For related compounds studied in longevity and cellular ageing research, explore our Longevity Research collection. For broader context on the peptide bioregulator class to which Epitalon belongs, see our Peptide Bioregulators Research Introduction.
Disclaimer: All products sold by Alpha Peptides are intended strictly for in vitro research and laboratory use only. They are not approved for human or veterinary use, and this article does not constitute medical advice.
0 comments